NCT00560963View on ClinicalTrials.gov

Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Advanced or Metastatic Pancreatic Adenocarcinoma
Interventions
DRUG

everolimus

Trial Locations (5)

Unknown

Novartis Investigative Site, Halle

Novartis Investigative Site, Merseburg

Novartis Investigative Site, München

Novartis Investigative Site, Oberstaufen

Novartis Investigative Site, Ulm

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY